Meixiao Zhan

4.1k total citations
115 papers, 3.1k citations indexed

About

Meixiao Zhan is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Meixiao Zhan has authored 115 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 30 papers in Biomedical Engineering and 23 papers in Oncology. Recurrent topics in Meixiao Zhan's work include Nanoplatforms for cancer theranostics (28 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Hepatocellular Carcinoma Treatment and Prognosis (12 papers). Meixiao Zhan is often cited by papers focused on Nanoplatforms for cancer theranostics (28 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Hepatocellular Carcinoma Treatment and Prognosis (12 papers). Meixiao Zhan collaborates with scholars based in China, United States and Lebanon. Meixiao Zhan's co-authors include Ligong Lu, Wei Zhao, Xianglong Hu, Xu He, Yongjie Xin, Siyu Lu, Zhixiong Wang, Shaojun Peng, Shengtao Yuan and Yanhong Su and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Meixiao Zhan

112 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meixiao Zhan China 33 1.2k 852 625 396 380 115 3.1k
Xue Yang China 30 1.3k 1.1× 688 0.8× 614 1.0× 408 1.0× 333 0.9× 156 3.2k
Qin Zeng China 26 872 0.7× 734 0.9× 281 0.4× 506 1.3× 207 0.5× 98 2.6k
Haruhiko Kamada Japan 38 1.6k 1.3× 570 0.7× 339 0.5× 413 1.0× 566 1.5× 140 3.8k
Seung Young Lee South Korea 34 2.0k 1.6× 1.2k 1.4× 826 1.3× 394 1.0× 1.2k 3.3× 129 4.9k
Haolu Wang Australia 30 1.1k 0.9× 1.0k 1.2× 297 0.5× 382 1.0× 490 1.3× 67 3.5k
Shen Gao China 36 1.8k 1.4× 834 1.0× 636 1.0× 354 0.9× 630 1.7× 142 3.7k
Zhuo Wang China 30 2.1k 1.7× 548 0.6× 802 1.3× 563 1.4× 128 0.3× 134 3.6k
Marco Cordani Spain 26 1.1k 0.9× 668 0.8× 459 0.7× 486 1.2× 413 1.1× 72 3.0k
Yan Ma China 31 1.8k 1.5× 710 0.8× 992 1.6× 289 0.7× 202 0.5× 85 3.4k
Manash K. Paul United States 26 1.3k 1.1× 477 0.6× 364 0.6× 715 1.8× 243 0.6× 72 3.0k

Countries citing papers authored by Meixiao Zhan

Since Specialization
Citations

This map shows the geographic impact of Meixiao Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meixiao Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meixiao Zhan more than expected).

Fields of papers citing papers by Meixiao Zhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meixiao Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meixiao Zhan. The network helps show where Meixiao Zhan may publish in the future.

Co-authorship network of co-authors of Meixiao Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Meixiao Zhan. A scholar is included among the top collaborators of Meixiao Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meixiao Zhan. Meixiao Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Yuxia, et al.. (2024). Harnessing CD8+ T cell dynamics in hepatitis B virus‐associated liver diseases: Insights, therapies and future directions. Clinical and Translational Medicine. 14(7). e1731–e1731. 8 indexed citations
2.
Zhan, Meixiao, et al.. (2023). TMSB4X: A novel prognostic marker for non-small cell lung cancer. Heliyon. 9(11). e21505–e21505. 7 indexed citations
3.
Zhan, Meixiao, et al.. (2023). The influence of the chemical composition of modified lecithins on their surface-active and emulsifying properties. SHILAP Revista de lepidopterología. 19(3). 48–57. 1 indexed citations
4.
Chan, Leung, Yongkang Liu, Yanhong Su, et al.. (2023). Cuproptosis‐Driven Enhancement of Thermotherapy by Sequentially Response Cu2‐xSe via Copper Chemical Transition. Advanced Functional Materials. 33(33). 57 indexed citations
5.
Jiang, Lei, Luan Li, Yongzhuang Liu, et al.. (2023). Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma. Frontiers in Pharmacology. 14. 1097277–1097277. 30 indexed citations
6.
Lu, Ligong, Zhiling Zhou, Jinying Lu, et al.. (2022). PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma. Gut. 71(12). 2551–2560. 71 indexed citations
7.
Hou, Xiaoying, Cong Du, Ligong Lu, et al.. (2022). Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells. World Journal of Surgical Oncology. 20(1). 37–37. 40 indexed citations
8.
Huang, Jingjun, Wensou Huang, Meixiao Zhan, et al.. (2021). Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 8. 1445–1458. 27 indexed citations
9.
Huang, Jianping, Xiao Zhang, Wei Zhao, et al.. (2021). A high resolution representation network with multi-path scale for retinal vessel segmentation. Computer Methods and Programs in Biomedicine. 208. 106206–106206. 35 indexed citations
10.
Yuan, Jie, Ji Yi, Meixiao Zhan, et al.. (2021). The web-based multiplex PCR primer design software Ultiplex and the associated experimental workflow: up to 100- plex multiplicity. BMC Genomics. 22(1). 835–835. 12 indexed citations
11.
Zhang, Zhiren, Zhiren Zhang, Wenting Li, et al.. (2021). Genetic Diversity and Characteristics of blaNDM-Positive Plasmids in Escherichia coli. Frontiers in Microbiology. 12. 729952–729952. 15 indexed citations
12.
Zhao, Wei, Yongjie Xin, Yongkang Liu, et al.. (2021). Effects of ML351 and tissue plasminogen activator combination therapy in a rat model of focal embolic stroke. Journal of Neurochemistry. 157(3). 586–598. 11 indexed citations
13.
Jin, Hao, Wei Zhao, Meixiao Zhan, et al.. (2021). Temporary vaccination clinic for COVID-19 in Zhuhai, China. Human Vaccines & Immunotherapeutics. 17(10). 3478–3480. 3 indexed citations
14.
Cao, Min‐Jie, et al.. (2020). Development of an Orally Bioavailable Isoliquiritigenin Self-Nanoemulsifying Drug Delivery System to Effectively Treat Ovalbumin-Induced Asthma. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Lu, Ligong, Hui Zhang, Meixiao Zhan, et al.. (2020). Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?. Frontiers in Cell and Developmental Biology. 8. 677–677. 47 indexed citations
16.
He, Xijing, Huijun Li, Meixiao Zhan, et al.. (2019). Camellia nitidissima Chi Extract Potentiates the Sensitivity of Gastric Cancer Cells to Paclitaxel via the Induction of Autophagy and Apoptosis. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Sun, Xiaohan, Yan Ding, Meixiao Zhan, et al.. (2019). Usp7 regulates Hippo pathway through deubiquitinating the transcriptional coactivator Yorkie. Nature Communications. 10(1). 411–411. 72 indexed citations
18.
Li, Xiaoqiu, Yangyang Zhao, Wei Jiang, et al.. (2019). Ultralong circulating choline phosphate liposomal nanomedicines for cascaded chemo-radiotherapy. Biomaterials Science. 7(4). 1335–1344. 15 indexed citations
19.
Quan, Yingyao, et al.. (2019). Resveratrol bidirectionally regulates insulin effects in skeletal muscle through alternation of intracellular redox homeostasis. Life Sciences. 242. 117188–117188. 13 indexed citations
20.
Zheng, Youbin, Jianwen Huang, Meixiao Zhan, et al.. (2014). Genetic variants in the KDR gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma. Tumor Biology. 35(11). 11473–11481. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xue Yang Breakdown of academic impact, for papers by Qin Zeng Breakdown of academic impact, for papers by Haruhiko Kamada Breakdown of academic impact, for papers by Seung Young Lee Breakdown of academic impact, for papers by Haolu Wang Breakdown of academic impact, for papers by Shen Gao Breakdown of academic impact, for papers by Zhuo Wang Breakdown of academic impact, for papers by Marco Cordani Breakdown of academic impact, for papers by Yan Ma Breakdown of academic impact, for papers by Manash K. Paul
Rankless by CCL
2026